Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II lenvatinib monotherapy in metastatic colorectal cancer after standard chemotherapy
jRCT1091220261Phase 2Completed
- Sponsor
- National Cancer Center Hospital
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lenvatinib in colorectal adenocarcinoma, sponsored by National Cancer Center Hospital. Primary endpoint: Disease control rate. Started Aug 2016; status: completed.
02
Drugs
lenvatinib
03
Conditions
colorectal adenocarcinoma
Beyond the preview
Go deeper on jRCT1091220261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1091220261.